Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept for inflammatory erosive hand osteoarthritis
NL-OMON20086Recruiting
- Sponsor
- Leiden University Medical Center, The Netherlands University of Padova, Italy Medical University of Vienna,Austria Ghent University Hospital, Belgium
- Start
- Mar 2008
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial in osteoarthritis (OA) comparing Etanercept with Placebo (2 arms). Primary endpoint: Joint pain over 24 weeks. Started Mar 2008; status: recruiting.
02
Drugs
etanercept
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NL-OMON20086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20086.